Citron Research Takes it to Intuitive Surgical (ISRG) Again
Tweet
Share
E-mailGet Alerts ISRG Hot Sheet
Join SI Premium – FREE
Intuitive Surgical (Nasdaq: ISRG) is up Monday amid Citron Research releasing >another bearish report surrounding new data for the company.
In particular, Citron accuses Intuitive Surgical of misusing statistical data and thinks the company is disregarding the FDA’s own guidance with regard to the use of the MAUDE dataset. The firm notes:
For the full report, click here. Shares of Intuitive are up 4.4 percent on the session.
In particular, Citron accuses Intuitive Surgical of misusing statistical data and thinks the company is disregarding the FDA’s own guidance with regard to the use of the MAUDE dataset. The firm notes:
September MAUDE reports have just been posted. Another 102 injury-type reports and another 4 death-type reports. This exceeds August's record high, which was itself four times any previous reporting period in the company's history.
For the full report, click here. Shares of Intuitive are up 4.4 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Mentioned Cautiously at Hunterbook
- RBC says these 3 retail stocks "screen most attractive in the current market"
- This pharma stock is added to BofA's "EMEA Q4 Top 10 Ideas" list
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
